title: Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.
abstract: The role of nitric oxide (NO) in the anti-leishmanial activity has been confirmed both in vitro and in vivo. Recently, we demonstrated that NO-mediated apoptosis-like amastigote death pathway is an important and highly regulated mechanism used for the clearance of Leishmania within infected murine macrophages stimulated to produce NO endogenously. To further characterize these important effector mechanisms in dog, a natural host-reservoir of L. infantum/L. chagasi, we have developed an ex vivo infection model of canine macrophages. Exposure of L. infantum-infected macrophages to autologous peripheral lymphocytes derived from dogs immunised with purified excreted-secreted antigens of L. infantum promastigotes (LiESAp) formulated with muramyl dipeptide (MDP) as adjuvant resulted in a significant leishmanicidal effect due to interferon (IFN)-gamma dependent macrophage activation. Concomitant accumulation of NO(3)(-)/NO(2)(-) in supernatants of co-cultured cells and in situ staining of parasites with terminal deoxynucleotidyltransferase-mediated dUTP nick-end labelling (TUNEL) and YOPRO-1 showed that NO-mediated apoptosis of intracellular L. infantum amastigotes is occurring in canine macrophages as previously observed in mouse models. Monitoring these parameters in dogs after immunisation and before experimental challenge can represent a useful and easy way to rapidly evaluate vaccine candidates against canine visceral leishmaniasis.
authors.affiliation: UR 008 Pathogénie des Trypanosomatidés, IRD (Institut de Recherche pour le Développement), B.P. 64501, 911 avenue Agropolis, 34394 Montpellier Cedex 1, France.
authors.forename: P
authors.initials: P
authors.lastname: Holzmuller
authors.forename: M
authors.initials: M
authors.lastname: Cavaleyra
authors.forename: J
authors.initials: J
authors.lastname: Moreaux
authors.forename: R
authors.initials: R
authors.lastname: Kovacic
authors.forename: P
authors.initials: P
authors.lastname: Vincendeau
authors.forename: G
authors.initials: G
authors.lastname: Papierok
authors.forename: J-L
authors.initials: JL
authors.lastname: Lemesre
mesh_terms: D000818:Animals; D000953:Antigens, Protozoan / Q000008:administration & dosage* / Q000302:isolation & purification; D017209:Apoptosis; D018920:Coculture Techniques; D004285:Dogs / Q000276:immunology* / Q000469:parasitology*; D005260:Female; D007114:Immunization; D007371:Interferon-gamma / Q000096:biosynthesis*; D015847:Interleukin-4 / Q000096:biosynthesis; D018314:Leishmania infantum / Q000166:cytology / Q000276:immunology* / Q000472:pathogenicity; D007898:Leishmaniasis, Visceral / Q000276:immunology / Q000469:parasitology / Q000662:veterinary; D008264:Macrophages / Q000276:immunology* / Q000469:parasitology*; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism*
chemical_list: D000953:Antigens, Protozoan; D015847:Interleukin-4; D009569:Nitric Oxide; D007371:Interferon-gamma